THC-dominant vape
THC-led formulation with defined cannabinoid potency.
Medical cannabis vape manufacturing
GMP-led contract manufacturing for THC-dominant, CBD-dominant, and custom cannabinoid vape products.
Vape product manufacturing
Cilo Cybin offers specialist contract manufacturing and formulation development services for medical cannabis vape products, supporting licensed partners across the international medical cannabis sector with consistent, high-quality, and commercially ready vape formulations.
Our vape manufacturing pathway is built around Good Manufacturing Practice principles, with processes designed to support formulation control, batch repeatability, accurate filling, hardware compatibility, documentation, quality checks, and regulated-market expectations. By applying PIC/S GMP guideline principles across formulation, production, filling, packaging, and release planning, we help customers develop medical cannabis vape products with the consistency required for professional international supply.
Cilo Cybin specialises in formulated vape products rather than live resin or rosin-based formats. While live resin and rosin products can offer a strain-derived profile, their natural variability can make batch-to-batch repeatability difficult to control at scale. Our approach focuses on controlled cannabinoid inputs, defined terpene profiles, measured formulation parameters, and repeatable finished-product specifications.
This allows our partners to develop vape products that are consistent, scalable, and aligned with the expectations of regulated medical cannabis markets.
Formulated vape development
Vape programs are developed around repeatable cannabinoid profiles, terpene consistency, viscosity, appearance, device compatibility, and finished-product performance rather than variable live resin or rosin profiles.
Formulated vapes built for repeatability
A successful vape product must balance cannabinoid potency, terpene profile, viscosity, flow behaviour, hardware compatibility, stability, appearance, flavour profile, and finished-product performance.
Cilo Cybin supports customers through a structured formulation and contract manufacturing process, from concept development through to formulation trials, scale-up, filling, packaging, stability planning, and batch documentation.
Our vape formulation services can support THC-dominant vapes, CBD-dominant vapes, balanced CBD:THC vapes, terpene-enhanced formulations, and bespoke multi-cannabinoid vape products developed around customer-specific market requirements.
THC-dominant vape formulations
THC-dominant vapes can be developed for partners requiring controlled tetrahydrocannabinol profiles with defined potency targets, terpene character, and compatible vape hardware.
THC-led formulation with defined cannabinoid potency.
THC formulation enhanced with selected terpene profiles.
THC-led formulation supported by cannabigerol.
THC formulation with cannabinol as a secondary cannabinoid.
Custom profiles including CBC, THCV, CBDV, or other permitted cannabinoids.
CBD-dominant vape formulations
CBD-dominant vapes can be developed for partners seeking cannabidiol-led products with controlled CBD concentration, flavour profile, terpene selection, and hardware compatibility.
CBD-led formulation with defined potency targets.
CBD formulation enhanced with selected terpene profiles.
CBD-led formulation supported by CBG.
CBD formulation with CBN as a secondary cannabinoid.
Custom profiles including CBC, THCV, CBDV, or other permitted cannabinoids.
Customer-specific cannabinoid ratios and terpene profiles where required.
Major cannabinoids, minor cannabinoids, and terpene systems
Cilo Cybin works with a broad range of cannabinoid and terpene inputs to help customers develop differentiated medical cannabis vape products.
Services can include major cannabinoids such as THC, CBD, CBG, and CBN, as well as minor and emerging cannabinoids including CBC, THCV, CBDV, and other customer-specific ingredients where suitable and permitted.
Terpene formulation can be developed around cannabis-derived or botanical profiles, strain-inspired blends, or bespoke systems for flavour, aroma, and finished-product identity.
Rather than relying on variable extract profiles, the formulated vape approach supports better control over cannabinoid ratios, terpene consistency, flavour profile, viscosity, appearance, and batch-to-batch repeatability.
Why formulated vapes instead of live resin or rosin
Vape hardware, filling, and finished-product presentation
Standard cartridge formats for defined cannabinoid formulations.
Closed-system formats for controlled product presentation.
Integrated device formats for ready-to-use commercial products.
Finished vape products prepared for partner brands.
Customer-specific artwork, labelling, and packaging formats.
Formulation, filling, packaging, and documentation built around a partner brief.
Stability planning and product performance
Stability work includes cannabinoid potency, terpene profile, appearance, viscosity, device compatibility, leakage, crystallisation, container-closure interaction, and other relevant finished-product attributes.
This helps customers make informed decisions on formulation design, hardware selection, packaging, shelf-life planning, and market-specific documentation.
A GMP-led partner for medical cannabis vape products
Cilo Cybin’s vape contract manufacturing service is designed for licensed cannabis companies, pharmaceutical partners, and medical cannabis brands that require controlled formulation, repeatable production, quality-led processes, and finished-product consistency.
For customers seeking THC-dominant vapes, CBD-dominant vapes, balanced CBD:THC vapes, terpene-enhanced formulations, or bespoke minor cannabinoid vape products, we provide a structured pathway from formulation through to finished product.
Speak to our team about your target cannabinoid profile, terpene requirements, vape format, hardware preference, fill volume, stability needs, packaging requirements, and intended market.